Solanezumab
Modify Date: 2023-01-17 18:38:01
Solanezumab structure
|
Common Name | Solanezumab | ||
|---|---|---|---|---|
| CAS Number | 955085-14-0 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of SolanezumabSolanezumab is a humanized monoclonal IgG1 antibody directed against the mid-domain of the amyloid-β (Aβ) peptide. Solanezumab has the potential for the research of Alzheimer’s disease[1]. |
| Name | Solanezumab |
|---|
| Description | Solanezumab is a humanized monoclonal IgG1 antibody directed against the mid-domain of the amyloid-β (Aβ) peptide. Solanezumab has the potential for the research of Alzheimer’s disease[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |